Jiangsu Vcare Pharmatech Co., Ltd.
PrivateLast Round
Series C
Extension
Jun 2, 2026
Total Funding Raised
$224.8M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Jiangsu Vcare Pharmatech Co., Ltd. is a biopharmaceutical company that focuses on innovative drug research and development and provides comprehensive pharmaceutical industry chain services including CRO and CDMO.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Clinical Trials, Pharma Supply Chain, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Jiangsu Vcare Pharmatech Co., Ltd. Comparables
Compare Jiangsu Vcare Pharmatech Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioDuro-Sundia | 74% | |
| Bayer AG | 73% | |
| Eli Lilly and Company | 73% |
Jiangsu Vcare Pharmatech Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Jun 2, 2026 | ||||
| Series C Extension | Jan 22, 2025 | ||||
| Series C | Jan 2, 2024 | ||||
| Series B | Dec 26, 2022 | ||||
| Series A | May 6, 2022 | ||||
Series A | Jul 29, 2021 |
Jiangsu Vcare Pharmatech Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hongcheng Capital | Series B |
| DYEE Capital | Series C |
| SDIC Capital Co., Ltd. | Series C Extension, Series B, Series A |
| 南京市创新投资集团有限责任公司 | Series C, Series A |
| China Life Private Equity Investment | Series C |
| Yangtze River Industry Group | Series A, Series B |
| China Life Private Equity Investment Co., Ltd. | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 133% MoM.
- Jun 2, 2026
$29.4M round completed.
Jiangsu Vcare Pharmatech Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Jiangsu Vcare Pharmatech Co., Ltd.'s valuation, stock price, and market status.
Is Jiangsu Vcare Pharmatech a public or private company?
Jiangsu Vcare Pharmatech is a private company.
What is the current stock price of Jiangsu Vcare Pharmatech?
Jiangsu Vcare Pharmatech is a private company with no public stock price. No recent secondary market data is available.
How much is Jiangsu Vcare Pharmatech worth (valuation)?
Valuation information for Jiangsu Vcare Pharmatech is not publicly available.
Can I buy Jiangsu Vcare Pharmatech stock?
Jiangsu Vcare Pharmatech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Jiangsu Vcare Pharmatech's last funding round?
Jiangsu Vcare Pharmatech's most recent funding round was Series C on January 2, 2024.
Who are the main investors in Jiangsu Vcare Pharmatech?
Key investors in Jiangsu Vcare Pharmatech include DYEE Capital, China Life Private Equity Investment.
Will Jiangsu Vcare Pharmatech IPO soon?
No public IPO plans have been announced for Jiangsu Vcare Pharmatech.
How can I track Jiangsu Vcare Pharmatech secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Jiangsu Vcare Pharmatech's secondary market activity and sign up for updates.